NewLink enters $150M deal to fund cancer therapy work

October 20, 2014 1:09 PM

10 0

An Ames-based pharmaceutical company has entered into a $150 million deal to further develop its cancer therapies.

NewLink Genetics said today that it has entered into an exclusive license agreement with Genentech, a San Francisco-based biotechnology firm.

Also read: Buffett's Berkshire Hathaway will not increase its Oncor offer

Read more

To category page